Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
van Os, J.
Walsh, E.
van Horn, E.
Tattan, T.
Bale, R.
and
Thompson, S.G
1999.
Tardive dyskinesia in psychosis: are women really more at risk?.
Acta Psychiatrica Scandinavica,
Vol. 99,
Issue. 4,
p.
288.
Eich, Ph.
1999.
Leponex.
p.
29.
Jager, Alan D.
2000.
Abnormal Movements in First Episode Psychosis.
Australasian Psychiatry,
Vol. 8,
Issue. 1,
p.
38.
Jablensky, A.
2000.
Psychiatrie der Gegenwart 5.
p.
3.
Jablensky, A.
2001.
Contemporary Psychiatry.
p.
1373.
McMahon, William M
Filloux, Francis M
Ashworth, James C
and
Jensen, Jenise
2002.
Movement disorders in children and adolescents.
Neurologic Clinics,
Vol. 20,
Issue. 4,
p.
1101.
Fernandez, Hubert H.
and
Friedman, Joseph H.
2003.
CLASSIFICATION AND TREATMENT OF TARDIVE SYNDROMES.
The Neurologist,
Vol. 9,
Issue. 1,
p.
16.
Blanchet, Pierre J.
2003.
Antipsychotic Drug-Induced Movement Disorders.
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques,
Vol. 30,
Issue. S1,
p.
S101.
2004.
Drug-Induced Movement Disorders.
Vol. 20045530,
Issue. ,
Dean, Charles E.
Russell, Jean M.
Kuskowski, Michael A.
Caligiuri, Michael P.
and
Nugent, Sean M.
2004.
Clinical Rating Scales and Instruments.
Journal of Clinical Psychopharmacology,
Vol. 24,
Issue. 3,
p.
298.
Lenzenweger, Mark F.
Maher, Brendan A.
and
Manschreck, Theo C.
2005.
Paul E. Meehl's influence on experimental psychopathology: Fruits of the nexus of schizotypy and schizophrenia, neurology, and methodology.
Journal of Clinical Psychology,
Vol. 61,
Issue. 10,
p.
1295.
Lohr, James B.
2005.
Drug Induced Movement Disorders.
p.
302.
McCreadie, Robin G.
Srinivasan, Tirupati N.
Padmavati, Raman
and
Thara, Rangaswamy
2005.
Extrapyramidal symptoms in unmedicated schizophrenia.
Journal of Psychiatric Research,
Vol. 39,
Issue. 3,
p.
261.
Honer, William G.
Kopala, Lili C.
and
Rabinowitz, Jonathan
2005.
Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
Journal of Psychopharmacology,
Vol. 19,
Issue. 3,
p.
277.
FRIEDMAN, JOSEPH H.
and
FERNANDEZ, HUBERT H.
2005.
Animal Models of Movement Disorders.
p.
713.
2006.
Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions.
p.
2438.
Tarsy, Daniel
and
Baldessarini, Ross J.
2006.
Epidemiology of tardive dyskinesia: Is risk declining with modern antipsychotics?.
Movement Disorders,
Vol. 21,
Issue. 5,
p.
589.
Ragheb, Moataz M
and
Goldberg, Richard J
2006.
Tardive Dyskinesia in Geriatric Patients.
Aging Health,
Vol. 2,
Issue. 5,
p.
833.
Shirzadi, Arshia A.
and
Ghaemi, Nassir S.
2006.
Side Effects of Atypical Antipsychotics: Extrapyramidal Symptoms and the Metabolic Syndrome.
Harvard Review of Psychiatry,
Vol. 14,
Issue. 3,
p.
152.
Fahn, Stanley
Jankovic, Joseph
Hallett, Mark
and
Jenner, Peter
2007.
Principles and Practice of Movement Disorders.
p.
479.
eLetters
No eLetters have been published for this article.